These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 29195036
1. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection. Mitchell BG, McMahon BC, Mitchell CW. Prim Care Companion CNS Disord; 2017 Nov 30; 19(6):. PubMed ID: 29195036 [No Abstract] [Full Text] [Related]
2. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report. Yamashita T, Fujii Y, Misawa F. J Clin Psychopharmacol; 2013 Feb 30; 33(1):127-9. PubMed ID: 23288234 [No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia. Mané A, Baeza I, Morer A, Lázaro ML, Bernardo M. J Child Adolesc Psychopharmacol; 2005 Dec 30; 15(6):844-5. PubMed ID: 16379503 [No Abstract] [Full Text] [Related]
5. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report. Mall GD, Hake L, Benjamin AB, Adityanjee A. J Clin Psychopharmacol; 2008 Oct 30; 28(5):572-3. PubMed ID: 18794658 [No Abstract] [Full Text] [Related]
6. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report. Ghio L, Fornaro G, Rossi P. J Clin Psychopharmacol; 2009 Aug 30; 29(4):391-2. PubMed ID: 19593182 [No Abstract] [Full Text] [Related]
12. Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine. Isbister GK, Dawson AH, Whyte IM. Ann Pharmacother; 2002 Mar 12; 36(7-8):1293; author reply 1294. PubMed ID: 12086569 [No Abstract] [Full Text] [Related]
13. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient]. Villanueva Lamas J, García García J, Alda Diez JA, Tous Andreu N. An Esp Pediatr; 1998 Dec 12; 49(6):652-3. PubMed ID: 9972639 [No Abstract] [Full Text] [Related]
14. Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: a case report. Lee SI, Klesmer J, Hirsch BE. Psychosomatics; 2000 Dec 12; 41(5):453-4. PubMed ID: 11015640 [No Abstract] [Full Text] [Related]
15. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome. Liu PY, Wu PC, Chen CY, Chen YC. Gen Hosp Psychiatry; 2011 Dec 12; 33(1):84.e5-7. PubMed ID: 21353143 [Abstract] [Full Text] [Related]
16. Atypical neuroleptic malignant syndrome associated with iloperidone administration. Guanci N, Aggarwal R, Schleifer S. Psychosomatics; 2012 Dec 12; 53(6):603-5. PubMed ID: 23157999 [No Abstract] [Full Text] [Related]